Interventions for Tuberculosis Control and Elimination
Next
Previous
First
Last
The policy to use six months of isoniazid became widespread and the common standard among any patient. A study with a five-year follow-up in Uganda among patients with HIV infection showed, however, that the five-year benefit of six months isoniazid was nil in comparison with placebo.
